Atea Pharmaceuticals Stock Market Value
| AVIR Stock | USD 4.45 0.29 6.97% |
| Symbol | Atea |
Can Pharmaceuticals industry sustain growth momentum? Does Atea have expansion opportunities? Factors like these will boost the valuation of Atea Pharmaceuticals. If investors know Atea will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Atea Pharmaceuticals demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 2.641 | Earnings Share (1.77) | Revenue Per Share | Quarterly Revenue Growth 2.952 | Return On Assets |
Atea Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Atea's balance sheet. Smart investors calculate Atea Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Atea Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Atea Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Atea Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Atea Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Atea Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Atea Pharmaceuticals.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Atea Pharmaceuticals on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Atea Pharmaceuticals or generate 0.0% return on investment in Atea Pharmaceuticals over 90 days. Atea Pharmaceuticals is related to or competes with Voyager Therapeutics, Vanda Pharmaceuticals, Allogene Therapeutics, Entrada Therapeutics, Pyxis Oncology, Humacyte, and Enanta Pharmaceuticals. Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commerci... More
Atea Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Atea Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Atea Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.78 | |||
| Information Ratio | 0.0999 | |||
| Maximum Drawdown | 17.79 | |||
| Value At Risk | (4.43) | |||
| Potential Upside | 5.54 |
Atea Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Atea Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Atea Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Atea Pharmaceuticals historical prices to predict the future Atea Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1091 | |||
| Jensen Alpha | 0.368 | |||
| Total Risk Alpha | 0.0712 | |||
| Sortino Ratio | 0.0915 | |||
| Treynor Ratio | 0.5884 |
Atea Pharmaceuticals February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1091 | |||
| Market Risk Adjusted Performance | 0.5984 | |||
| Mean Deviation | 2.29 | |||
| Semi Deviation | 3.16 | |||
| Downside Deviation | 3.78 | |||
| Coefficient Of Variation | 789.3 | |||
| Standard Deviation | 3.46 | |||
| Variance | 11.96 | |||
| Information Ratio | 0.0999 | |||
| Jensen Alpha | 0.368 | |||
| Total Risk Alpha | 0.0712 | |||
| Sortino Ratio | 0.0915 | |||
| Treynor Ratio | 0.5884 | |||
| Maximum Drawdown | 17.79 | |||
| Value At Risk | (4.43) | |||
| Potential Upside | 5.54 | |||
| Downside Variance | 14.25 | |||
| Semi Variance | 10.01 | |||
| Expected Short fall | (2.36) | |||
| Skewness | 0.1219 | |||
| Kurtosis | 4.56 |
Atea Pharmaceuticals Backtested Returns
Atea Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Atea Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18 % return per unit of standard deviation over the last 3 months. By analyzing Atea Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of Atea Pharmaceuticals' mean deviation of 2.29, and Risk Adjusted Performance of 0.1091 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Atea Pharmaceuticals holds a performance score of 14. The firm shows a Beta (market volatility) of 0.73, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Atea Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Atea Pharmaceuticals is expected to be smaller as well. Please check Atea Pharmaceuticals' standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Atea Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.72 |
Good predictability
Atea Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Atea Pharmaceuticals time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Atea Pharmaceuticals price movement. The serial correlation of 0.72 indicates that around 72.0% of current Atea Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.64 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Pair Trading with Atea Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Atea Stock
| 0.77 | JNJ | Johnson Johnson | PairCorr |
| 0.69 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.77 | LPCN | Lipocine | PairCorr |
Moving against Atea Stock
| 0.8 | HPQ | HP Inc | PairCorr |
| 0.72 | MSFT | Microsoft | PairCorr |
| 0.53 | BRK-A | Berkshire Hathaway | PairCorr |
| 0.53 | MMM | 3M Company | PairCorr |
| 0.52 | VLCN | Volcon Inc Symbol Change | PairCorr |
The ability to find closely correlated positions to Atea Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea Pharmaceuticals to buy it.
The correlation of Atea Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Atea Stock Analysis
When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.